Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance

被引：0

作者：

Hirotsugu Uemura

Yoshihiko Tomita

Norio Nonomura

Kenji Yoshizaki

Takafumi Nakao

Nobuo Shinohara

机构：

[1] Kindai University Faculty of Medicine,Department of Urology

[2] Niigata University Graduate School of Medical and Dental Sciences,Department of Urology, Department of Molecular Oncology

[3] Osaka University Graduate School of Medicine,Department of Urology

[4] Ono Pharmaceutical Co.,Safety Management Pharmacovigilance Division

[5] Ltd.,Department of Renal and Genitourinary Surgery

[6] Hokkaido University Graduate School of Medicine,undefined

来源：

International Journal of Clinical Oncology | 2022年 / 27卷

关键词：

Effectiveness; Japan; Nivolumab; Post-marketing surveillance; Safety; Un-resectable or metastatic renal cell carcinoma;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1061 / 1067

页数：6

共 50 条

[11] Safety and effectiveness of avelumab in patients with curatively unresectable merkel cell carcinoma (MCC) in a real-world setting: A post-marketing surveillance in Japan.
Uhara, Hisashi
Kiyohara, Yoshio
Sato, Masashi
Endo, Shehla
Song, Bingbing
Sato, Yoshinori
Tanaka, Yutaro
Kambe, Anzu
Yamazaki, Naoya
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[12] Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
Hyeongyeong Kim
Youngdoe Kim
YoungJa Lee
[J]. Rheumatology and Therapy, 2021, 8 : 1393 - 1404
[13] Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
Kim, Hyeongyeong
Kim, Youngdoe
Lee, YoungJa
[J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (03) : 1393 - 1404
[14] Real-World Safety and Effectiveness of Adalimumab in Patients with Juvenile Idiopathic Arthritis: Results from a Post-Marketing Surveillance in Japan
Takei, Syuji
Iwata, Naomi
Kobayashi, Ichiro
Igarashi, Toru
Yoshinaga, Yoko
Matsubara, Naoko
Sunaga, Naomi
Ito, Ayumi
Yokota, Shumpei
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[15] Real-world safety and effectiveness of rotigotine in patients with Parkinson's disease: analysis of a post-marketing surveillance study in Japan
Ito, Hidefumi
Takayama, Tomoyo
Kondo, Hiroyuki
Fukuta, Yasuhiko
[J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2022, 132 (03) : 237 - 247
[16] Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database
Wataya, Takafumi
Takasaki, Sakura
Hoshino, Misuzu
Makioka, Haruki
Nakamura, Genshu
Matsuda, Naoto
[J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (08) : 851 - 863
[17] Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan
Fukuda, Masaki
Hattori, Junko
Ohkubo, Rika
Watanabe, Asuka
Maekawa, Shinichiroh
[J]. CLINICAL DRUG INVESTIGATION, 2024, 44 (07) : 527 - 540
[18] Real-world effectiveness and safety of golimumab in patients with ulcerative colitis: 52-weeks of post-marketing surveillance data in Japan
Nakamura, S.
Asano, T.
Tanaka, Y.
Sugimoto, K.
Yoshigoe, S.
Suzuki, Y.
[J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I439 - I441
[19] Real-world effectiveness and safety of golimumab in patients with ulcerative colitis: 52-weeks of post-marketing surveillance data in Japan
Nakamura, S.
Asano, T.
Tanaka, Y.
Sugimoto, K.
Yoshigoe, S.
Suzuki, Y.
[J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I439 - I441
[20] Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing study
Kang, Wonseok
Kim, Yoon Jun
Kim, Seung Up
Seo, Yeon Seok
Kim, Jin-Wook
Kim, Ji Hoon
Park, Soo Young
Baek, Yang-Hyun
Kim, Kang Mo
Lee, Hae Lim
Yoon, Ki Tae
Kim, Hyeyeong
Cheong, Jae Youn
Hwang, Jae Seok
Kim, Ju Hyun
Kim, Kwang Min
Sung, Pil Soo
Kim, Jieun
Kim, Do Young
[J]. FUTURE ONCOLOGY, 2024,

← 1 2 3 4 5 →